Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 1531-1540 of 9367

Page
per page
  1. AI-10-49
    A8694 AI-10-49
    Summary: A selective leukemia oncoprotein CBFβ-SMHHC inhibitor
      ≥16.53 mg/mL
  2. FIIN-2
    A8696 FIIN-2
    Target: FGFR
    Summary: Irreversible inhibitor of FGFR
      ≥31.75 mg/mL
  3. Stiripentol
    A8704 Stiripentol
    Target: Lactate Dehydrogenases (LDH)
    Summary: An LDH inhibitor
  4. SCR7
    A8705 SCR7
     6 Citation
    Summary: DNA ligase IV inhibitor
      insoluble in H2O; ≥16.72 mg/mL
  5. HPOB
    B4890 HPOB
     1 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC6 inhibitor, potent and selective
      ≥31.4 mg/mL
  6. ML324
    B4891 ML324
     1 Citation
    Summary: JMJD2 demethylase inhibitor, potent and cell-permeable
      insoluble in H2O; ≥17.45 mg/mL
  7. TAI-1
    B4892 TAI-1
    Target: Hec1
    Summary: Hec1 inhibitor, potent, first-in-class
      ≥43.2 mg/mL
  8. LDC1267
    B4893 LDC1267
    Target: TAM kinase
    Summary: TAM kinase inhibitor,highly selective
      insoluble in H2O; insoluble in EtOH; ≥20.75 mg/mL
  9. SP2509
    B4894 SP2509
    Target: Histone Demethylases
    Summary: Demethylase 1 (LSD1) antagonist, novel Lysine-specific
      insoluble in H2O; insoluble in EtOH; ≥19.45 mg/mL
  10. OF-1
    B4895 OF-1
    Summary: BRPF1B and BRPF2 bromodomain inhibitor
      insoluble in H2O; insoluble in EtOH; ≥14.55 mg/mL

Items 1531-1540 of 9367

Page
per page